Tenax Therapeutics (TENX) Cash from Investing Activities (2010 - 2023)
Tenax Therapeutics recorded quarterly Cash from Investing Activities of $157.0 in Q4 2023, down 90.2% quarter-over-quarter from $1602.0 in Q2 2023, and down 96.08% year-over-year from $4000.0 in Q4 2022.
Tenax Therapeutics' Cash from Investing Activities history runs 14 years deep, the most recent figure standing at $157.0 for Q4 2023.
- In Q4 2023, Cash from Investing Activities fell 96.08% year-over-year to $157.0; the TTM figure through Sep 2024 stood at $157.0 (down 97.71% YoY), while the FY2023 annual figure was $3000.0, up 229.14% from the prior year.
- Cash from Investing Activities came in at $157.0 for Q4 2023 at Tenax Therapeutics, down from $1602.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $511538.0 in Q3 2021 to a low of -$36964.0 in Q1 2021.
- A 5-year average of $27749.6 and a median of $157.0 in 2023 frame the typical range for Cash from Investing Activities.
- On a YoY basis, Cash from Investing Activities climbed as much as 18902.15% in 2021 and fell as far as 483.95% in 2021.
- Tenax Therapeutics' Cash from Investing Activities stood at -$16747.0 in 2019, then jumped by 120.94% to $3506.0 in 2020, then sank by 148.43% to -$1698.0 in 2021, then soared by 335.57% to $4000.0 in 2022, then plunged by 96.08% to $157.0 in 2023.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $157.0, $1602.0, and $1241.0 for Q4 2023, Q2 2023, and Q1 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 157.00 |
| Dec 31, 2023 | 157.00 |
| Jun 30, 2023 | 1,602.00 |
| Jun 30, 2023 | 1,602.00 |
| Mar 31, 2023 | 1,241.00 |
| Mar 31, 2023 | 1,241.00 |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Mar 31, 2022 | -6,323.00 |
| Mar 31, 2022 | -6,323.00 |
| Dec 31, 2021 | -1,698.00 |
| Dec 31, 2021 | -1,698.00 |
| Sep 30, 2021 | 511,538.00 |
| Sep 30, 2021 | 511,538.00 |
| Jun 30, 2021 | -20,267.00 |
| Jun 30, 2021 | -20,267.00 |
| Mar 31, 2021 | -36,964.00 |
| Mar 31, 2021 | -36,964.00 |
| Dec 31, 2020 | 3,506.00 |
| Dec 31, 2020 | 3,506.00 |
| Sep 30, 2020 | 2,692.00 |
| Sep 30, 2020 | 2,692.00 |
| Jun 30, 2020 | 20,241.00 |
| Jun 30, 2020 | 20,241.00 |
| Mar 31, 2020 | -6,330.00 |
| Mar 31, 2020 | -6,330.00 |
| Dec 31, 2019 | -16,747.00 |
| Dec 31, 2019 | -16,747.00 |
| Sep 30, 2019 | 24,105.00 |
| Sep 30, 2019 | 24,105.00 |
| Jun 30, 2019 | -204.00 |
| Jun 30, 2019 | -204.00 |
| Mar 31, 2019 | -8,805.00 |
| Mar 31, 2019 | -8,805.00 |
| Dec 31, 2018 | 1.31 Mn |
| Dec 31, 2018 | 1.31 Mn |
| Sep 30, 2018 | 1.00 Mn |
| Sep 30, 2018 | 1.00 Mn |
| Jun 30, 2018 | 2.10 Mn |
| Jun 30, 2018 | 2.10 Mn |
| Mar 31, 2018 | 2.95 Mn |
| Mar 31, 2018 | 2.95 Mn |
| Dec 31, 2017 | 1.12 Mn |
| Dec 31, 2017 | 1.12 Mn |
| Sep 30, 2017 | 756,129.00 |
| Sep 30, 2017 | 756,129.00 |
| Jun 30, 2017 | 800,501.00 |
| Jun 30, 2017 | 800,501.00 |
| Mar 31, 2017 | 1.07 Mn |
| Mar 31, 2017 | 1.07 Mn |
| Dec 31, 2016 | 12.38 Mn |
| Dec 31, 2016 | 12.38 Mn |
| Sep 30, 2016 | 3.07 Mn |
| Sep 30, 2016 | 3.07 Mn |
| Jun 30, 2016 | 3.83 Mn |
| Jun 30, 2016 | 3.83 Mn |
| Mar 31, 2016 | 2.92 Mn |
| Mar 31, 2016 | 2.92 Mn |
| Dec 31, 2015 | 4.78 Mn |
| Dec 31, 2015 | 4.78 Mn |
| Sep 30, 2015 | -388,415.00 |
| Sep 30, 2015 | -388,415.00 |
| Jun 30, 2015 | 35.03 Mn |
| Jun 30, 2015 | 35.03 Mn |
| Jul 31, 2014 | -34.58 Mn |
| Jul 31, 2014 | -34.58 Mn |
| Apr 30, 2014 | -33,994.00 |
| Apr 30, 2014 | -33,994.00 |
| Jan 31, 2014 | -44,177.00 |
| Jan 31, 2014 | -44,177.00 |
| Oct 31, 2013 | -35,711.00 |
| Oct 31, 2013 | -35,711.00 |
| Jul 31, 2013 | -33,156.00 |
| Jul 31, 2013 | -33,156.00 |
| Apr 30, 2013 | -42,052.00 |
| Apr 30, 2013 | -42,052.00 |
| Jan 31, 2013 | -35,154.00 |
| Jan 31, 2013 | -35,154.00 |
| Oct 31, 2012 | -36,653.00 |
| Oct 31, 2012 | -36,653.00 |
| Jul 31, 2012 | -34,128.00 |
| Jul 31, 2012 | -34,128.00 |
| Apr 30, 2012 | -53,946.00 |
| Apr 30, 2012 | -53,946.00 |
| Jan 31, 2012 | -45,725.00 |
| Jan 31, 2012 | -45,725.00 |
| Oct 31, 2011 | -74,791.00 |
| Oct 31, 2011 | -74,791.00 |
| Jul 31, 2011 | -86,684.00 |
| Jul 31, 2011 | -86,684.00 |
| Apr 30, 2011 | -93,312.00 |
| Apr 30, 2011 | -93,312.00 |
| Jan 31, 2011 | -113,325.00 |
| Jan 31, 2011 | -113,325.00 |
| Oct 31, 2010 | -98,181.00 |
| Oct 31, 2010 | -98,181.00 |
| Jul 31, 2010 | -159,121.00 |
| Jul 31, 2010 | -159,121.00 |